Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term methods. Found 465 abstracts

no pagination
Fisher SG, Devlin A. Development of an urban community-based cohort to promote health disparities research. International journal of public health. 2019 Sep;64(7):1107-15.
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet (London, England). 2019 Jan 05;393(10166):40-50.   PMCID: PMC6541928
Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall JB, Yang X, Hocker JD, Escobar TM, He S, Dell'Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate. Nat Commun. 2019 May 14;10(1):2157.   PMCID: PMC6517388
Monshi SS, Halpern MT. Factors associated with smoking cessation and smoking cessation interventions in the Gulf Cooperation Council countries. Saudi Med J. 2019 Feb;40(2):119-25.   PMCID: PMC6402472
Necchi A, Mariani L, Lo Vullo S, Yu EY, Woods ME, Wong YN, Harshman LC, Alva A, Sternberg CN, Bamias A, Grivas P, Koshkin VS, Roghmann F, Dobruch J, Eigl BJ, Nappi L, Milowsky MI, Niegisch G, Pal SK, De Giorgi U, Recine F, Vaishampayan U, Berthold DD, Bowles DW, Baniel J, Theodore C, Ladoire S, Srinivas S, Agarwal N, Crabb S, Sridhar S, Golshayan AR, Ohlmann C, Xylinas E, Powles T, Rosenberg JE, Bellmunt J, van Rhijn B, Galsky MD, Hendricksen K. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis. European urology focus. 2019 Mar;5(2):242-9.   PMCID: PMC5712487
Rouvinov K, Plimack ER, Zibelman M, Ghatalia P, Geynisman DM. Update on perioperative systemic therapy for urothelial carcinoma. Clinical advances in hematology & oncology : H&O. 2019 Mar;17(3):176-83.
Adolf-Bryfogle J, Kalyuzhniy O, Kubitz M, Weitzner BD, Hu X, Adachi Y, Schief WR, Dunbrack RL. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design. PLoS computational biology. 2018 Apr 27;14(4):e1006112.   PMCID: PMC5942852
Berry KE. Estimating Fluoroscopic Peak Skin Dose Using Manual Calculations. Health physics. 2018 Jun;114(6):649-53.
Collins BN, Lepore SJ, Winickoff JP, Nair US, Moughan B, Bryant-Stephens T, Davey A, Taylor D, Fleece D, Godfrey M. An Office-Initiated Multilevel Intervention for Tobacco Smoke Exposure: A Randomized Trial. Pediatrics. 2018 Jan;141(Suppl 1):S75-s86.   PMCID: PMC5745677 conflicts of interest to disclose.
Edwards DC, Cahn DB, Smaldone MC, Kutikov A. Use of administrative data for comparative effectiveness research in the treatment of non-prostate genitourinary malignancies. Urol Oncol. 2018 Apr;36(4):193-212.
Gerson JN, Ramamurthy C, Borghaei H. Managing adverse effects of immunotherapy. Clinical advances in hematology & oncology : H&O. 2018 May;16(5):364-74.   PMCID: Review
Graves KD, Hall MJ, Tercyak KP. Introduction to the special issue on clinical and public health genomics: Opportunities for translational behavioral medicine research, practice, and policy. Translational behavioral medicine. 2018 Jan 29;8(1):4-6.   PMCID: PMC6065537
Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, Wallace RE, Spratt DE, Hamstra DA. A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. Practical radiation oncology. 2018 Jan;8(1):40-7.
Jelinek J, Lee JT, Cesaroni M, Madzo J, Liang S, Lu Y, Issa JJ. Digital Restriction Enzyme Analysis of Methylation (DREAM). Methods Mol Biol. 2018 Jan;1708:247-65.
Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. Jama. 2018 Mar 06;319(9):896-905.   PMCID: PMC5885899
Li M, Sohn JA, Seeger C. Distribution of Hepatitis B Virus Nuclear DNA. J Virol. 2018 Jan;92(1).   PMCID: PMC5730781
Marty Pyke R, Thompson WK, Salem RM, Font-Burgada J, Zanetti M, Carter H. Evolutionary Pressure against MHC Class II Binding Cancer Mutations. Cell. 2018 Oct 04;175(2):416-428e13.   PMCID: PMC6482006
Mikropoulos C, Selkirk CG, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, Jensen T, Osther PJ, van Asperen CJ, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Hart R, Glover W, Lam J, Taylor L, Salinas M, Feliubadalo L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Cook J, Rosario DJ, Buys SS, Conner T, Domchek S, Powers J, Ausems MG, Teixeira MR, Maia S, Izatt L, Schmutzler R, Rhiem K, Foulkes WD, Boshari T, Davidson R, Ruijs M, Helderman-van den Enden AT, Andrews L, Walker L, Snape K, Henderson A, Jobson I, Lindeman GJ, Liljegren A, Harris M, Adank MA, Kirk J, Taylor A, Susman R, Chen-Shtoyerman R, Pachter N, Spigelman A, Side L, Zgajnar J, Mora J, Brewer C, Gadea N, Brady AF, Gallagher D, van Os T, Donaldson A, Stefansdottir V, Barwell J, James PA, Murphy D, Friedman E, Nicolai N, Greenhalgh L, Obeid E, Murthy V, Copakova L, McGrath J, Teo SH, Strom S, Kast K, Leongamornlert DA, Chamberlain A, Pope J, Newlin AC, Aaronson N, Ardern-Jones A, Bangma C, Castro E, Dearnaley D, Eyfjord J, Falconer A, Foster CS, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Lubinski J, Grindedal EM, McKinley J, Shackleton K, Mitra AV, Moynihan C, Rennert G, Suri M, Tricker K, Moss S, Kote-Jarai Z, Vickers A, Lilja H, Helfand BT, Eeles RA. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. Br J Cancer. 2018 Jan;118(2):266-76.   PMCID: PMC5785754
Necchi A, Pond GR, Smaldone MC, Pal SK, Chan K, Wong YN, Viterbo R, Sonpavde G, Harshman LC, Crabb S, Alva A, Chowdhury S, De Giorgi U, Srinivas S, Agarwal N, Bamias A, Baniel J, Golshayan AR, Ladoire S, Sternberg CN, Cerbone L, Yu EY, Bellmunt J, Vaishampayan U, Niegisch G, Hussain S, Bowles DW, Morales-Barrera R, Milowsky MI, Theodore C, Berthold DR, Sridhar SS, Powles T, Rosenberg JE, Galsky MD. Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study. European urology focus. 2018 Dec;4(6):937-45.   PMCID: PMC5626651
Roach M, Moughan J, Lawton CA, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR, Shipley WU, Sandler HM. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 Nov;19(11):1504-15.   PMCID: PMC6540797
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term methods

methods Male pathology Middle Aged genetics therapy therapeutic use metabolism Aged Female immunology Prostatic Neoplasms Adult adverse effects Retrospective Studies Treatment Outcome mortality Urinary Bladder Neoplasms drug therapy Antineoplastic Agents Neoplasm Grading Neoplasm Staging administration & dosage Urothelial carcinoma surgery Prostate-Specific Antigen Cystectomy virology Lymph Node Excision prevention & control Propensity Score Neoplasm Metastasis statistics & numerical data Kallikreins Lymph Nodes Transitional Cell Carcinoma Logistic Models Cisplatin Immunotherapy Neoplasm Invasiveness 80 and over Aged Smoking Cessation CD8-Positive T-Lymphocytes Progression-Free Survival Chemoradiotherapy Drug Administration Schedule Neoadjuvant Therapy Neoplastic Gene Expression Regulation Adjuvant Chemotherapy Radiation Dosage Adoptive Transfer Neoplasms Inbred C57BL Mice Administrative databases Monoclonal Antibodies psychology Radiosurgery Software Cohort Studies Interventional Radiography Patient Compliance Urogenital Neoplasms High-Throughput Nucleotide Sequencing cancer Kaplan-Meier Estimate Robotic Surgical Procedures MicroRNAs covalently closed circular DNA Perioperative chemotherapy immunotherapy Squamous Cell Carcinoma of Head and Neck BRCA1 Protein tumor evolution Cohort Hepatitis Genomics Radiation Monitoring Smoking Cessation Agents Next-generation sequencing Pennsylvania Ethnic Groups Ambulatory Care Oncologists Mutation 4 Phosphatidylinositol-3-5-Trisphosphate 5-Phosphatases DNA Methylation Directive Counseling Socioeconomic Factors Skin Neoplasms Age Factors epidemiology antivirals Tobacco Smoke Pollution Survival Analysis Oropharyngeal Neoplasms Outcomes based research Restriction Mapping CD4-Positive T-Lymphocytes Propensity-score Leuprolide Research Mhc-ii Disease Progression Patient Acceptance of Health Care blood Duck Hepatitis B Virus Multivariate Analysis Complementarity Determining Regions Self Efficacy Molecular Models Flutamide Tobacco Use Cessation Monte Carlo Method Community-based Early Detection of Cancer First-line chemotherapy Carcinoma transplantation CTLA-4 Antigen Attitudes Health Knowledge-Practice Hepatocytes Canada Environmental Pollution Proportional Hazards Models B7-H1 Antigen Hematologic Neoplasms Prostatectomy Counseling Registries Molecular Evolution Datasets as Topic Follow-Up Studies DNA methylation Randomized Controlled Trials as Topic Urothelium Intensity-Modulated Radiotherapy etiology Histocompatibility Antigens Class I Patient Education as Topic Robot-assisted surgery Health disparities drug effects Viral DNA Social Support Circular DNA Experimental Melanoma Dermatitis Amino Acid Sequence Tobacco Smoking Health Status Disparities
Last updated on Wednesday, March 04, 2020